BIT's 12th Annual World Cancer Congress-2019(WCC-2019)

WCC-2019 will provide a unique and ideal opportunity for a broad spectrum of researchers, clinicians and other health professionals to meet, discuss, share, learn and connect in order to find solutions to reduce the impact of cancer in the world. With the participation of outstanding international experts,


BIT's 12th Annual World Cancer Congress-2019(WCC-2019)will be held on May 15-17, 2019 in Osaka, Japan.
Given the major worldwide importance in cancer research, cancer therapies, and new drug trials, we should not only help ensure we’re apprised of current developments in the field but also reflect on new progress and look toward future challenges.

Past Renowned Speakers of WCC-2018
说明: 1-Giorgio Massimini.jpg Dr. Giorgio Massimini, Vice President & Head Medical Officer, Global Research & Development, EMD Serono- Merck KgaA, Germany 说明: 2-Vladimir Lazar.jpg Dr. Vladimir Lazar, Chief Scientific and Operating Officer, WIN Consortium, France 说明: 3-Zang-Hee Cho.jpg Dr. Zang-Hee Cho, Endowed Chair Professor & Director, Neuroscience Research Institute, Suwon University & Seoul National University, South Korea
说明: 4-Sergey Suchkov.jpg Dr. Serghei Suchkov, Director, Center for Personalized Medicine, Sechenob University; Chair, Department for Translational Medicine, Moscow Engineering Physical Institute, Russia 说明: Stefan J. Scherer.jpg Dr. Stefan Scherer, Vice President & Head Early Development, Strategy and Innovation, Novartis Pharmaceutical Corporation, USA 说明: Franklin Sallisbury.jpg Dr. Franklin Sallisbury, CEO, National Foundation for Cances Research, USA
Dr. Brian Leyland-Jones, Vice President & Director of Precision Oncology Mc Keenan Avera Cancer Institute; Director of WIN Consortium, France 说明: Dominique Belpomme.png Dr. Dominique Belpomme, Professor, University of Paris; Director, the European Cancer and Environment Research Institute (ECERI), France 说明: Juan Sanabria.jpg Dr. Juan Sanabria, Professor, Vice-chair & Scientific Director, Comprehensive Cancer Center, USA
Exhibition and Poster

As part of the 2019 World Cancer Congress, an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of cancer. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.

Exhibitors' advantages
• The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries.
• The exhibitors have the opportunity to present their exhibits more detailed, and have the opportunity for longer discussion with inquiring visitors – in most cases specialists – than during session discussions.


Exhibition Date:
Set-up date: May 15, 2019
Show dates: May 15-17, 2019 09:00-18:00
Place: Osaka,Japan

Hosting Organization

BIT Group Global Ltd.

Supporting Organization
International Honorary Chairmen

Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France

Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA

Official Travel Agency
BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2017-2018 BIT Congress Inc.